Homebrewed psilocybin: can new routes for pharmaceutical psilocybin production enable recreational use?

Psilocybin, a drug most commonly recognized as a recreational psychedelic, is quickly gaining attention as a promising therapy for an expanding range of neurological conditions, including depression, anxiety, and addiction. This growing interest has led to many recent advancements in psilocybin synt...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: William J. Gibbons, Madeline G. McKinney, Philip J. O’Dell, Brooke A. Bollinger, J. Andrew Jones
Format: article
Langue:EN
Publié: Taylor & Francis Group 2021
Sujets:
Accès en ligne:https://doaj.org/article/d8bd116372e74aefb9a4cdaa8d2ccdf3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!